Expedia Group, Inc. (NASDAQ:EXPE – Get Free Report) saw a large drop in short interest in November. As of November 30th, there was short interest totalling 4,300,000 shares, a drop of 13.0% from the November 15th total of 4,940,000 shares. Based on an average trading volume of 1,440,000 shares, the days-to-cover ratio is presently 3.0 days. Currently, 3.6% of the company’s stock are short sold.
Expedia Group Price Performance
EXPE stock opened at $183.00 on Friday. The business’s fifty day moving average price is $171.80 and its 200 day moving average price is $144.92. Expedia Group has a 12-month low of $107.25 and a 12-month high of $192.34. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 2.03. The company has a market capitalization of $23.49 billion, a PE ratio of 23.55, a P/E/G ratio of 1.07 and a beta of 1.84.
Insider Buying and Selling
In other Expedia Group news, CAO Lance A. Soliday sold 7,000 shares of Expedia Group stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $181.99, for a total value of $1,273,930.00. Following the completion of the sale, the chief accounting officer now owns 11,187 shares of the company’s stock, valued at approximately $2,035,922.13. This trade represents a 38.49 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Dara Khosrowshahi sold 10,000 shares of the company’s stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $150.21, for a total transaction of $1,502,100.00. Following the transaction, the director now owns 208,505 shares in the company, valued at $31,319,536.05. This represents a 4.58 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 38,951 shares of company stock worth $6,197,710 in the last three months. 6.80% of the stock is owned by corporate insiders.
Institutional Investors Weigh In On Expedia Group
Analysts Set New Price Targets
EXPE has been the subject of a number of recent research reports. TD Cowen downgraded Expedia Group from a “buy” rating to a “hold” rating and boosted their price target for the company from $130.00 to $150.00 in a research note on Wednesday, September 25th. Bank of America increased their price target on shares of Expedia Group from $144.00 to $166.00 and gave the stock a “neutral” rating in a research report on Friday, October 25th. DA Davidson boosted their price objective on shares of Expedia Group from $135.00 to $190.00 and gave the company a “neutral” rating in a research report on Monday, November 18th. Benchmark raised their target price on Expedia Group from $180.00 to $200.00 and gave the stock a “buy” rating in a report on Friday, November 8th. Finally, StockNews.com raised Expedia Group from a “buy” rating to a “strong-buy” rating in a report on Saturday. Twenty investment analysts have rated the stock with a hold rating, eight have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, Expedia Group has an average rating of “Hold” and an average target price of $167.67.
View Our Latest Report on EXPE
About Expedia Group
Expedia Group, Inc operates as an online travel company in the United States and internationally. The company operates through B2C, B2B, and trivago segments. Its B2C segment includes Brand Expedia, a full-service online travel brand offers various travel products and services; Hotels.com for lodging accommodations; Vrbo, an online marketplace for the alternative accommodations; Orbitz, Travelocity, Wotif Group, ebookers, CheapTickets, Hotwire.com and CarRentals.com.
Featured Articles
- Five stocks we like better than Expedia Group
- The 3 Best Blue-Chip Stocks to Buy Now
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Top Stocks Investing in 5G Technology
- Texas Instruments: The Old-School Tech Titan Still Delivering
- The Most Important Warren Buffett Stock for Investors: His Own
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Expedia Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Expedia Group and related companies with MarketBeat.com's FREE daily email newsletter.